You searched for London - Page 30 of 35

In Depth 18 Feb 2025

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

…Engagers – Imperial College London Candid Therapeutics on a T cell engagers partnership spree As biotechs boost their T cell engager pipelines, many are looking for partnerships to do so….

February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter

In Depth 7 Jan 2020

A Different Culture Shaping Synthetic Biology in Europe

…approach,” said Neil Goldsmith, founder of London-based investment group Double Bioventures. Goldsmith was quick to point out a big oddity of the synthetic biology space, which is that, except for…

January 7, 2020 - 8 minutesmins - By David Kirk

News and Trends 5 Feb 2018

New Antiviral for RSV Lung Infections Shows Promise in Phase IIa

ReViral’s candidate RV521 showed its potential for the treatment of respiratory syncytial virus (RSV) infections by reducing viral load and mucus levels. London-based biotech ReViral discovers and develops antiviral drugs,…

February 5, 2018 - 3 minutesmins - By Alex Dale

Tiziana Life Sciences HCC milciclib cancer

News and Trends 19 Jul 2017

Update: British Biotech Starts Phase II Trial in the Second Deadliest Cancer

…an ambitious biotech in London targeting some of the most challenging autoimmune and inflammatory diseases, from type 1 diabetes to rheumatoid arthritis. The company just announced the approval of a…

July 19, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 1 May 2019

What’s Driving the Boom in Early Stage Biotech Funding?

…J&J’s four ‘innovation centers’ in London, Shanghai, Boston and California, where the company brings together a network of scientists and investors. Rather than taking a controlling role in the companies…

May 1, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Sep 2016

The Munich Biotech Mafia are at it again, raising €40M for an I/O Startup

…greater proportion of cancer patients.” Sebastian Meier-Ewert, CEO. Competition in this field is intense. Abingworth just bestowed its financial graces upon a new London-based startup; big pharma is partnering up…

September 23, 2016 - 2 minutesmins - By Evelyn Warner

Podcast 31 Mar 2023

Beyond Biotech podcast 40: Antibody-drug conjugates

…on the surface of cancer cells, which are uniquely tumor selective and potentially suitable for development as antibody-drug conjugates. The company talked about those applications recently at World ADC London…

March 31, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 1 May 2019

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

…London-based biotech company Cell Medica is working on a next-generation treatment called CAR-NKT cell therapy. Where conventional CAR-T therapy genetically engineers the patient’s immune T cells to attack cancer cells,…

May 1, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

In Depth 13 Jun 2022

DNA synthesis: tackling the main bottleneck in biology research

…technologies,” said Paul Freemont, professor at Imperial College London and director of the UK Innovation and Knowledge Centre for Synthetic Biology, also known as SynbiCITE. “About one gram of DNA…

June 13, 2022 - 10 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 2 Apr 2019

The 8 Best Biotech Companies in Europe’s History

…antibodies from over 500 companies. Soon it started to grow, entering the London Stock Exchange in 2005, where it’s valued at over €2Bn today. In 2011, the company took a…

April 2, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Nov 2017

Welcome to Amsterdam, EMA! Your New Home Post-Brexit

…with over 70% thinking about quitting if it moved to Bratislava. The soon-to-be former home of the EMA in Canary Wharf, London. The winner was decided through a rather complicated…

November 21, 2017 - 3 minutesmins - By Alex Dale

News and Trends 1 May 2019

UK Genome Diagnostics Biotech Closes €27M Series B to Support NHS

…well as to allow the company to expand internationally. The genomics diagnostic company received a €15.5M (£13.3M) investment, led by the London-based fund management firm Parkwalk and joined by new…

May 1, 2019 - 2 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: London

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

A Different Culture Shaping Synthetic Biology in Europe

New Antiviral for RSV Lung Infections Shows Promise in Phase IIa

Update: British Biotech Starts Phase II Trial in the Second Deadliest Cancer

What’s Driving the Boom in Early Stage Biotech Funding?

The Munich Biotech Mafia are at it again, raising €40M for an I/O Startup

Beyond Biotech podcast 40: Antibody-drug conjugates

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

DNA synthesis: tackling the main bottleneck in biology research

The 8 Best Biotech Companies in Europe’s History

Welcome to Amsterdam, EMA! Your New Home Post-Brexit

UK Genome Diagnostics Biotech Closes €27M Series B to Support NHS

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!